|
Media Count:
N/A
|
|
Date:
Aug 1996
|
|
Author:
J. Parker G. Clinton
|
The HER-2/neu (c-erbB2) protooncogene is overexpressed in up to 30% of breast and ovarian cancers. Overexpression as a 185 kilodalton transmembrane growth-factor-receptor/ tyrosine-kinase (pl85HER%2) is an indicator of poor prognosis. Attempting to charac ...
|
|
Report Number:
N/A
|
|
|
Contract Number:
DAMD17-94-J-4179
|
|
Project Number:
N/A
|
|
Grant Number:
N/A
|
|
Task Number:
N/A
|
|
NTIS announcement issue:
9705
|
"N/A" indicates no data is available for this field.
|
|
